Key Points
-
Oklo, developing advanced nuclear reactors, reported a pre-revenue operating loss of $124.2 million in early 2026.
-
Cameco, generating steady revenue from uranium production and services, announced its uranium segment achieved 676 million CAD ($483 million USD) in adjusted EBITDA for the first half of 2026.
-
Analysts rate Oklo a “moderate buy” with potential 230% upside, while Cameco is rated a “strong buy” with a 55% target price increase.
Oklo focuses on next-generation reactors aimed at data centers and has been granted preliminary safety approval for its Aurora powerhouse in Ohio. Its revenue was only $1.21 million, with operational expenses totaling $74 million. In contrast, Cameco has established contracts for over 28 million pounds of uranium deliveries annually from 2026 through 2030, providing a more stable revenue base.
The global electricity demand is expected to grow at an annual rate of 3.6% from 2026 to 2030, with U.S. demand projected to rise by nearly 2% per year, creating opportunities for both companies within the nuclear sector.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
